Study of Retinoic Acid-Induced Osteoarthritis: Integrating RNA-Sequencing, Network Pharmacology, Molecular Docking, and Experimental Validation
Open Access
- 9 June 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (12) , 5519
Abstract
Osteoarthritis (OA) is a debilitating joint disorder characterized by cartilage degradation and disruption of chondrocyte homeostasis. Although retinoic acid (RA) has been used in OA models, its precise targets are not clear. A translational framework was employed, integrating RNA-sequencing results, network pharmacology prediction, computational ligand-receptor molecular docking, and biological experimental validation, to systematically elucidate RA’s disease-modifying targets in OA pathogenesis. RNA-sequencing of RA-treated chondrocytes revealed 656 differentially expressed genes (DEGs). Protein–protein interaction (PPI) network analysis and functional enrichment [Gene Ontology (GO)/Kyoto Encyclopedia of Genes and Genomes (KEGG)] highlighted key pathways, including extracellular matrix (ECM) reorganization and PI3K-Akt-mediated mechanotransduction and others. Network pharmacology analysis identified 42 shared targets between RA and OA. PPI analysis and functional enrichment (GO/KEGG) highlighted pathways including the renin–angiotensin system and the neuroactive ligand–receptor interaction, among others. Molecular docking ranked candidate targets by binding affinity of RA in descending order as MAPK14 (p38α), PTGER3 (PGE2 receptor), CA2 (CA2), and others. Five intersecting targets CA2, ACE, PTGS1 (COX-1), PGR, and EDNRA (ETAR) were identified by integrating RNA-sequencing (RNA-seq) results and network pharmacology predictions. These interactions were experimentally validated via western blot, RT-qPCR and immunofluorescence. RA increased the expression of MMP13, CA2 and ACE, and decreased the expression of COL2A1 in chondrocytes. siRNA-mediated knockdown of both CA2 (human CA2 homolog) and ACE (human ACE homolog) inhibit cartilage degradation through downregulating MMP13 and upregulating COL2A1. This study not only elucidates potential molecular mechanisms by which RA modulates chondrocyte catabolism but also offers a valuable reference for the development of novel OA therapeutics.Keywords
Funding Information
- Da Tong Key Research Project of Science and Technology Planning (2024025, 81902306, 82174406, 2024QN012)
- National Natural Science Foundation of China (2024025, 81902306, 82174406, 2024QN012)
- Shanghai Municipal Health Commission Traditional Chinese Medicine Research Project (2024025, 81902306, 82174406, 2024QN012)
This publication has 53 references indexed in Scilit:
- Interplay within tumor microenvironment orchestrates neoplastic RNA metabolism and transcriptome diversityWIREs RNA, 2021
- Naproxen attenuates osteoarthritis progression through inhibiting the expression of prostaglandinl‐endoperoxide synthase 1Journal of Cellular Physiology, 2018
- The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence AnalysesCurrent Protocols in Bioinformatics, 2016
- Excessive Retinoic Acid Impaired Proliferation and Differentiation of Human Fetal Palatal Chondrocytes (hFPCs)Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2014
- Transforming growth factor‐alpha induces endothelin receptor A expression in osteoarthritisJournal of Orthopaedic Research, 2012
- Osteoarthritis: A disease of the joint as an organArthritis & Rheumatism, 2012
- Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based searchJournal of Computer-Aided Molecular Design, 2007
- Carbonic Anhydrase II Plays a Major Role in Osteoclast Differentiation and Bone Resorption by Effecting the Steady State Intracellular pH and Ca2+Experimental Cell Research, 1998
- Effects of all-trans-retinoyl-β- d -glucuronide and all-trans-retinoic acid on chondrogenesis and retinoid metabolism in mouse limb bud mesenchymal cells in vitroArchives of Toxicology, 1997
- Retinoid Teratogenesis: Toxicokinetics and Structure-Specificity1994